Σύγκριση μεθόδων

	Ανάλυση Κόστους-Οφέλους (ΑΚΟ)	Ανάλυση Κόστους-Αποτελεσματικότητας (CEA)
Πεδίο	Οικονομικά της Υγείας	Οικονομικά της Υγείας
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1970s	1984
Δημιουργός	Boardman, Greenberg, and colleagues (welfare economics)	Drummond & Stoddart (Health Economics Research Group, McMaster University)
Τύπος	Method	Method
Θεμελιώδης πηγή	Boardman, A. E., Greenberg, D. H., Vining, A. R., & Weimer, D. L. (2018). Cost-Benefit Analysis: Concepts and Practice (5th ed.). Cambridge: Cambridge University Press.	Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press.
Εναλλακτικές ονομασίες	CBA, economic appraisal, benefit-cost ratio	CEA, ICER, Incremental Cost-Effectiveness Ratio
Συναφείς	5	5
Σύνοψη	Cost-benefit analysis compares the total monetary value of benefits produced by a program against its total monetary costs, reporting net present value (NPV) or benefit-cost ratio (BCR). Rooted in welfare economics and used extensively in public policy (transportation, environmental, education, health), CBA answers the question: 'Is this program worth doing from a societal perspective?' Unlike cost-effectiveness analysis, CBA monetizes both costs and benefits, enabling comparison across disparate program types.	Cost-effectiveness analysis compares the incremental cost per unit of health benefit gained by one intervention relative to a comparator (standard care or best alternative). Developed rigorously in the 1980s by Drummond, Stoddart, and colleagues, CEA is now the standard framework for technology appraisal globally. NICE, HAS, CADTH, and other health technology assessment bodies use CEA to decide which treatments warrant public funding and at what price.